Vikas Lifecare
- P/E
- Not meaningful: last twelve months’ earnings are mostly a one-off item
Key Fundamentals
MicrocapCommercial ServicesServicesPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 2.16%
- Debt to Equity
- 0.19
- EPS (TTM)
- ₹0.09
- Book Value
- ₹2.97
- Market Cap
- —
- P/E (TTM)
- Not meaningful: last twelve months’ earnings are mostly a one-off item
- P/B
- 0.39
- ROE
- 3.40%
- Dividend Yield
- 0.00%
- EBITDA
- −₹116 Cr
- 52W High
- ₹2.08
- 52W Low
- ₹1.05
- Day Range
- ₹1.10 – ₹1.17
- Volume
- 30,38,528
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 60
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 59
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 47
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 40
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 25
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Stock is trading at 0.40 times its book value
- Company has delivered good profit growth of 50.0% CAGR over last 5 years
- Company's working capital requirements have reduced from 99.9 days to 74.1 days
Weaknesses
3- Promoter holding is low: 14.2%
- Company has a low return on equity of 1.80% over last 3 years.
- Earnings include an other income of Rs.136 Cr.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 4 | 4 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 46.44
- Neutral
- MACD (12,26,9)
- −0.03
- Bearish
- SMA (50)
- 1.21
- Bearish
- SMA (200)
- 1.40
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +46.09% |
|---|---|
| 3Y | +1.59% |
| 1Y | +3.96% |
Net profit
| 5Y | Turned to profit |
|---|---|
| 3Y | Turned to profit |
| 1Y | Turned to profit |
Operating cash flow
| 5Y | Turned positive |
|---|---|
| 3Y | Turned positive |
| 1Y | Turned positive |
Operating margin· change in pp
| 5Y | −33.92 pp |
|---|---|
| 3Y | −25.77 pp |
| 1Y | −21.58 pp |
Trailing twelve months: The last four quarters end with the latest fiscal year, which the 1Y column covers.
Revenue by year
| Mar 2021 | ₹75.00 Cr |
|---|---|
| Mar 2022 | ₹301 Cr |
| Mar 2023 | ₹476 Cr |
| Mar 2024 | ₹446 Cr |
| Mar 2025 | ₹480 Cr |
| Mar 2026 | ₹499 Cr |
Net profit by year
| Mar 2021 | −₹4.00 Cr |
|---|---|
| Mar 2022 | ₹29.00 Cr |
| Mar 2023 | −₹16.00 Cr |
| Mar 2024 | ₹13.00 Cr |
| Mar 2025 | −₹11.00 Cr |
| Mar 2026 | ₹18.00 Cr |
Quarterly Results
₹ CrResults for the period ended Jun 2026 were due by 14 Aug 2026 and are not in this table yet.
| Particulars | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 118 | 99 | 116 | 99 | 132 | 92 | 135 | 118 | 135 | 92 | 141 | 97 | 169 |
| Expenses | 117 | 96 | 114 | 104 | 128 | 92 | 136 | 121 | 158 | 98 | 259 | 127 | 195 |
| Operating Profit | 1 | 3 | 2 | −5 | 4 | 0 | −1 | −3 | −23 | −6 | −118 | −30 | −26 |
| OPM % | 1.1% | 2.7% | 2% | −4.8% | 2.7% | −0.3% | −1% | −2.7% | −17% | −6% | −83% | −31% | −16% |
| Other Income | −32 | 12 | 7 | 3 | −2 | 2 | 3 | −1 | 21 | 133 | 1 | 1 | 65 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 2 | 1 |
| PBT | −32 | 13 | 8 | −3 | −1 | 0 | −1 | −7 | −5 | 125 | −120 | −33 | 35 |
| Tax % | −17% | 9% | 2% | 28% | 222% | 9833% | −349% | 1% | −46% | 0% | −1% | −12% | −18% |
| Net Profit | −27 | 12 | 8 | −4 | −2 | −3 | 2 | −7 | −3 | 125 | −119 | −29 | 42 |
| EPS (₹) | −0.19 | 0.08 | 0.05 | −0.02 | −0.01 | −0.02 | 0.01 | −0.04 | −0.02 | 0.67 | −0.64 | −0.16 | 0.22 |
Profit & Loss
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 75 | 301 | 476 | 446 | 480 | 499 |
| Expenses | 67 | 302 | 464 | 442 | 488 | 616 |
| Operating Profit | 8 | −1 | 12 | 4 | −8 | −116 |
| OPM % | 10% | −0.3% | 2.5% | 0.9% | −1.6% | −23% |
| Other Income | −3 | 44 | −28 | 20 | 6 | 136 |
| Interest | 5 | 2 | 2 | 3 | 5 | 7 |
| Depreciation | 1 | 2 | 3 | 4 | 7 | 6 |
| PBT | −2 | 39 | −21 | 17 | −13 | 7 |
| Tax % | 133% | 26% | −27% | 21% | −15% | −157% |
| Net Profit | −4 | 29 | −16 | 13 | −11 | 18 |
| EPS (₹) | −0.03 | 0.26 | −0.11 | 0.09 | −0.06 | 0.1 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 66 | 110 | 144 | 165 | 186 | 186 |
| Reserves | 0 | 90 | 187 | 311 | 346 | 366 |
| Borrowings | 42 | 23 | 30 | 34 | 77 | 105 |
| Other Liabilities | 41 | 98 | 93 | 44 | 121 | 103 |
| Total Liabilities | 149 | 321 | 454 | 555 | 729 | 760 |
| Fixed Assets | 12 | 28 | 47 | 56 | 61 | 36 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 0 |
| Investments | 3 | 84 | 77 | 183 | 54 | 394 |
| Other Assets | 133 | 208 | 330 | 316 | 614 | 330 |
| Total Assets | 149 | 321 | 454 | 555 | 729 | 760 |
Cash Flow
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | −8 | −15 | −112 | −42 | −222 | 310 |
| Investing | 12 | −37 | −36 | −91 | 106 | −334 |
| Financing | −4 | 59 | 151 | 137 | 108 | 20 |
| Net Cash Flow | 0 | 8 | 2 | 4 | −8 | −5 |
| Free Cash Flow | −9 | −28 | −130 | −51 | −234 | 317 |
| CFO/OP | −90 | 1,565 | −949 | −1,045 | 2,905 | −270 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 347 | 52 | 130 | 120 | 97 | 103 |
| Inventory Days | 156 | 36 | 10 | 8 | 4 | 4 |
| Days Payable | 216 | 84 | 48 | 13 | 47 | 44 |
| Cash Conversion Cycle | 287 | 4 | 92 | 115 | 54 | 62 |
| Working Capital Days | 270 | 12 | 85 | 141 | 85 | 74 |
| ROCE % | — | 19% | −7% | 4% | 0% | 2% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vikas Lifecare insights
62 extracted metrics across FY20–FY26.
Documents
- 24 Jun 2026
- 18 Jan 2022
- General announcements 17 Sep 2026
- General announcements 8 Sep 2026
- General announcements 15 Jul 2026
- General announcements 11 Jul 2026
Frequently Asked Questions about Vikas Lifecare
What does Vikas Lifecare Ltd do?
Where is Vikas Lifecare Ltd (VIKASLIFE) listed?
Which sector does Vikas Lifecare Ltd belong to?
What is the 52-week high and low of Vikas Lifecare Ltd?
What is the Return on Equity (ROE) of Vikas Lifecare Ltd?
Company Information
Incorporated in 1995, Vikas Lifecare Ltd is under four business segments which is trading(Base polymers, additives and chemicals meant for plastic processing, commodity compounds( Manufacturing up-cycled polymer compounds like EVA, PVC, PP,PE etc.), Environment protection( Recycling and up-cycling of plastic waste to fulfill EPR) and FMCG & Healthcare which can be further divided into different major segments which include Smart product Business( Smart gas and water meters), Polymer & Chemical Business (Recycling materials, trading and manufacturing of Polymer Compounds), FMCG segment (Agro Product), Infra Products( Steel fittings & Steel Bars), Food grade piping system for Jal Jeevan Mission.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VIKASLIFE.md for Vikas Lifecare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.